Summary
- BREGO Life Sciences launched RISE to support healthcare professionals pursuing clinical research.
- The programme focuses on research and case studies in joint and nerve health.
- Up to 40 selected submissions may receive research development opportunities.
KUALA LUMPUR, October 14 — BREGO Life Sciences has launched the RISE Programme to help Malaysian healthcare professionals develop clinician-led research in joint and nerve health.
RISE, short for Research, Innovation & Scientific Excellence, provides a structured pathway from clinical research ideas to independent scientific evaluation.
Eligible healthcare professionals can submit research or case study abstracts, with up to 20 submissions selected in each therapeutic area for potential research development opportunities.
Top-performing studies may receive further support based on scientific merit, clinical relevance and feasibility. The 2026/2027 submission cycle is expected to remain open until the end of January 2027.
